Search

everythinglearnresearchcommunity

for

Search:↓

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Dutasteride is safe and effective long-term for male hair loss.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Some psychotropic medications can rarely cause hair loss, and stopping these drugs usually reverses the condition.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Clotrimazole, miconazole, and tolnaftate are likely safe, but gentian violet is risky.

Different parts of the body have unique immune characteristics in their skin.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Neuregulin3 affects cell development in the skin and mammary glands.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Alopecia in dogs is often caused by mange, flea and tick infestations, and nutritional deficiencies, especially in males and young dogs.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

New biomaterial treatments for baldness show promise, with options depending on patient needs.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Older age and specific haircare practices increase the risk of traction alopecia, and education on these factors could help prevent it.

Hirsutism greatly lowers the quality of life for Turkish women.

Nanocarrier technology in cosmetics improves ingredient delivery and effectiveness while reducing side effects.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

Using tissue expanders and hyaluronidase in scalp reduction surgery allows for more scalp removal and easier surgery.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

New materials and methods could improve skin healing and reduce scarring.